381 related articles for article (PubMed ID: 35903371)
1. Digital Interventions to Save Lives From the Opioid Crisis Prior and During the SARS COVID-19 Pandemic: A Scoping Review of Australian and Canadian Experiences.
Donnell A; Unnithan C; Tyndall J; Hanna F
Front Public Health; 2022; 10():900733. PubMed ID: 35903371
[TBL] [Abstract][Full Text] [Related]
2. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
[TBL] [Abstract][Full Text] [Related]
3. Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada.
Strike C; Watson TM
Int J Drug Policy; 2019 Sep; 71():178-182. PubMed ID: 30975595
[TBL] [Abstract][Full Text] [Related]
4. A Dynamic Model of Opioid Overdose Deaths in Canada during the Co-Occurring Opioid Overdose Crisis and COVID-19 Pandemic.
Zahan R; Osgood ND; Plouffe R; Orpana H
Int J Environ Res Public Health; 2024 Apr; 21(4):. PubMed ID: 38673354
[TBL] [Abstract][Full Text] [Related]
5. Short- and Long-Term Predicted and Witnessed Consequences of Digital Surveillance During the COVID-19 Pandemic: Scoping Review.
Comer L; Donelle L; Hiebert B; Smith MJ; Kothari A; Stranges S; Gilliland J; Long J; Burkell J; Shelley JJ; Hall J; Shelley J; Cooke T; Ngole Dione M; Facca D
JMIR Public Health Surveill; 2024 May; 10():e47154. PubMed ID: 38788212
[TBL] [Abstract][Full Text] [Related]
6. The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review.
Alexander K; Pogorzelska-Maziarz M; Gerolamo A; Hassen N; Kelly EL; Rising KL
Subst Abuse Treat Prev Policy; 2021 Aug; 16(1):60. PubMed ID: 34372900
[TBL] [Abstract][Full Text] [Related]
7. The Public Health Approach to the Worsening Opioid Crisis in the United States Calls for Harm Reduction Strategies to Mitigate the Harm From Opioid Addiction and Overdose Deaths.
Yeo Y; Johnson R; Heng C
Mil Med; 2022 Aug; 187(9-10):244-247. PubMed ID: 34908134
[TBL] [Abstract][Full Text] [Related]
8. Impact of the COVID-19 pandemic on opioid overdose and other adverse events in the USA and Canada: a systematic review.
Simha S; Ahmed Y; Brummett CM; Waljee JF; Englesbe MJ; Bicket MC
Reg Anesth Pain Med; 2023 Jan; 48(1):37-43. PubMed ID: 36202619
[TBL] [Abstract][Full Text] [Related]
9. Lessons from digital technology-enabled health interventions implemented during the coronavirus pandemic to improve maternal and birth outcomes: a global scoping review.
Moise IK; Ivanova N; Wilson C; Wilson S; Halwindi H; Spika VM
BMC Pregnancy Childbirth; 2023 Mar; 23(1):195. PubMed ID: 36941565
[TBL] [Abstract][Full Text] [Related]
10. Bridging the Gap in Harm Reduction Using Mobile Overdose Response Services (MORS) in the Context of the COVID-19 Pandemic: A Qualitative Study.
Seo B; Rioux W; Rider N; Teare A; Jones S; Taplay P; Ghosh SM
J Urban Health; 2024 Apr; 101(2):252-261. PubMed ID: 38514599
[TBL] [Abstract][Full Text] [Related]
11. CAEP Position Statement: Emergency department management of people with opioid use disorder.
Koh JJ; Klaiman M; Miles I; Cook J; Kumar T; Sheikh H; Dong K; Orkin AM; Ali S; Shouldice E
CJEM; 2020 Nov; 22(6):768-771. PubMed ID: 33028446
[TBL] [Abstract][Full Text] [Related]
12. From telehealth to virtual primary care in Australia? A Rapid scoping review.
Jonnagaddala J; Godinho MA; Liaw ST
Int J Med Inform; 2021 Jul; 151():104470. PubMed ID: 34000481
[TBL] [Abstract][Full Text] [Related]
13. Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect.
Manchikanti L; Singh VM; Staats PS; Trescot AM; Prunskis J; Knezevic NN; Soin A; Kaye AD; Atluri S; Boswell MV; Abd-Elsayed A; Hirsch JA
Pain Physician; 2022 Mar; 25(2):97-124. PubMed ID: 35322965
[TBL] [Abstract][Full Text] [Related]
14. The Impact of the COVID-19 Pandemic on Drug Use Behaviors, Fentanyl Exposure, and Harm Reduction Service Support among People Who Use Drugs in Rural Settings.
Bolinski RS; Walters S; Salisbury-Afshar E; Ouellet LJ; Jenkins WD; Almirol E; Van Ham B; Fletcher S; Johnson C; Schneider JA; Ompad D; Pho MT
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206421
[TBL] [Abstract][Full Text] [Related]
15. Electronic harm reduction interventions for drug overdose monitoring and prevention: A scoping review.
Loverock A; Marshall T; Viste D; Safi F; Rioux W; Sedaghat N; Kennedy M; Ghosh SM
Drug Alcohol Depend; 2023 Sep; 250():110878. PubMed ID: 37441959
[TBL] [Abstract][Full Text] [Related]
16. Digital interventions for substance use disorders in young people: rapid review.
Monarque M; Sabetti J; Ferrari M
Subst Abuse Treat Prev Policy; 2023 Feb; 18(1):13. PubMed ID: 36805783
[TBL] [Abstract][Full Text] [Related]
17. Public Health Implications of Adapting HIV Pre-exposure Prophylaxis Programs for Virtual Service Delivery in the Context of the COVID-19 Pandemic: Systematic Review.
Patel P; Kerzner M; Reed JB; Sullivan PS; El-Sadr WM
JMIR Public Health Surveill; 2022 Jun; 8(6):e37479. PubMed ID: 35486813
[TBL] [Abstract][Full Text] [Related]
18. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?
Napoletano S; Basile G; Lo Faro AF; Negro F
Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997
[TBL] [Abstract][Full Text] [Related]
19. Overdose Alert and Response Technologies: State-of-the-art Review.
Oteo A; Daneshvar H; Baldacchino A; Matheson C
J Med Internet Res; 2023 Feb; 25():e40389. PubMed ID: 36790860
[TBL] [Abstract][Full Text] [Related]
20. Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study.
Galarneau LR; Hilburt J; O'Neill ZR; Buxton JA; Scheuermeyer FX; Dong K; Kaczorowski J; Orkin AM; Barbic SP; Bath M; Moe J; Miles I; Tobin D; Grier S; Garrod E; Kestler A
PLoS One; 2021; 16(7):e0255396. PubMed ID: 34324589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
